By the end of the century there will be an estimated 30 million people over age 65 in the
United States. Thus, the practice of medicine will deal with an older and more debilitated …

The authors studied 138 patients, 57 of whom were younger than 65 years of age and 81
who were 65 years of age and older, with community‐acquired pneumonia to determine …

The effectiveness of pneumococcal vaccine in the immunocompetent elderly remains
controversial. We report the results of a multicenter, case-control study of 244 controls and …

Pneumonia in the elderly is a common and serious problem with a clinical presentation that
can differ from that in younger patients. Older patients with pneumonia complain of …

Infectious diseases account for one third of all deaths in people 65 years and older. Early
detection is more difficult in the elderly because the typical signs and symptoms, such as …

In 2000, pneumococcal conjugate vaccine (PCV7) was recommended for young children. By
2002–2003, 48.6% had been fully immunized. Using Medicare administrative, we found that …

Pneumonia is a leading cause of morbidity and mortality among patients in long-term care
facilities; the median reported incidence is 1 per 1,000 patient-days. Risk factors include …

The incidence of pneumonia for elderly persons living in the community is 14 cases/1000
persons/y, whereas 33/1000 nursing home residents require hospitalization for pneumonia …

Rationale: Pneumococcal colonization is key to the pathogenesis of invasive disease but is
also immunogenic in young adults, protecting against recolonization. Colonization is rarely …

During October 1995-June 1996, CDC and state and local public health agencies
investigated outbreaks of pneumococcal pneumonia with bacteremia at chronic-care …